Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cencora, Inc. stock logo
COR
Cencora
$294.58
-1.1%
$292.19
$218.65
$309.35
$57.73B0.571.50 million shs803,583 shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$69.50
+0.3%
$71.80
$60.56
$82.49
$8.44B0.871.74 million shs1.35 million shs
McKesson Corporation stock logo
MCK
McKesson
$710.87
-0.7%
$716.12
$464.42
$737.89
$89.55B0.48917,305 shs402,202 shs
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$8.00
+0.9%
$7.67
$6.07
$16.98
$612.63M1.41.19 million shs841,656 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cencora, Inc. stock logo
COR
Cencora
-1.09%-0.92%+0.48%+2.63%+30.84%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
+0.26%-6.75%-0.94%+7.37%-2.42%
McKesson Corporation stock logo
MCK
McKesson
-0.66%-0.45%-1.88%+1.96%+22.07%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
+0.58%-3.41%+6.36%+15.16%-46.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cencora, Inc. stock logo
COR
Cencora
4.4916 of 5 stars
2.42.03.33.13.63.31.3
Henry Schein, Inc. stock logo
HSIC
Henry Schein
4.2941 of 5 stars
3.23.00.03.42.01.71.9
McKesson Corporation stock logo
MCK
McKesson
4.5906 of 5 stars
2.43.03.33.02.92.51.9
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
4.6169 of 5 stars
3.13.00.03.91.81.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cencora, Inc. stock logo
COR
Cencora
2.75
Moderate Buy$309.835.18% Upside
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.36
Hold$78.3612.75% Upside
McKesson Corporation stock logo
MCK
McKesson
2.86
Moderate Buy$710.17-0.10% Downside
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
2.20
Hold$11.6045.04% Upside

Current Analyst Ratings Breakdown

Latest OMI, HSIC, MCK, and COR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
Cencora, Inc. stock logo
COR
Cencora
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$313.00 ➝ $330.00
7/16/2025
McKesson Corporation stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$770.00 ➝ $810.00
7/14/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$75.00
7/14/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/14/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Neutral$82.00 ➝ $72.00
7/9/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$72.00 ➝ $78.00
7/9/2025
McKesson Corporation stock logo
MCK
McKesson
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$760.00 ➝ $800.00
6/30/2025
Cencora, Inc. stock logo
COR
Cencora
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$275.00 ➝ $300.00
6/11/2025
McKesson Corporation stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$745.00 ➝ $770.00
6/6/2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$9.00 ➝ $10.00
6/3/2025
Cencora, Inc. stock logo
COR
Cencora
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$274.00 ➝ $337.00
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cencora, Inc. stock logo
COR
Cencora
$293.96B0.19$19.67 per share14.98$4.04 per share72.92
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$12.67B0.67$7.35 per share9.46$32.33 per share2.15
McKesson Corporation stock logo
MCK
McKesson
$359.05B0.25$38.59 per share18.42($13.52) per share-52.58
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$10.70B0.06$9.09 per share0.88$7.33 per share1.09
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cencora, Inc. stock logo
COR
Cencora
$1.51B$8.6234.1717.451.480.55%344.71%4.26%8/6/2025 (Confirmed)
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$390M$3.2021.7213.842.243.21%14.87%5.82%8/5/2025 (Estimated)
McKesson Corporation stock logo
MCK
McKesson
$3.30B$25.8327.5219.401.430.92%-201.12%5.83%8/6/2025 (Estimated)
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
-$362.69M-$4.75N/A4.540.35-3.41%17.09%2.47%8/1/2025 (Estimated)

Latest OMI, HSIC, MCK, and COR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q3 2025
Cencora, Inc. stock logo
COR
Cencora
$3.79N/AN/AN/A$80.34 billionN/A
8/6/2025Q1 2026
McKesson Corporation stock logo
MCK
McKesson
$8.33N/AN/AN/A$95.93 billionN/A
8/5/2025Q2 2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.19N/AN/AN/A$3.22 billionN/A
8/1/2025Q2 2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$0.27N/AN/AN/A$2.73 billionN/A
5/10/2025Q1 2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$0.20$0.23+$0.03N/AN/AN/A
5/8/2025Q4 2025
McKesson Corporation stock logo
MCK
McKesson
$9.83$10.12+$0.29$10.01$94.00 billion$90.82 billion
5/8/2025Q1 2025
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$0.20$0.23+$0.03-$0.32$2.66 billion$2.63 billion
5/7/2025Q2 2025
Cencora, Inc. stock logo
COR
Cencora
$4.07$4.42+$0.35$3.68$75.41 billion$75.50 billion
5/5/2025Q1 2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.11$1.15+$0.04$0.88$3.24 billion$3.17 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cencora, Inc. stock logo
COR
Cencora
$2.200.75%N/A25.52%15 Years
Henry Schein, Inc. stock logo
HSIC
Henry Schein
N/AN/AN/AN/AN/A
McKesson Corporation stock logo
MCK
McKesson
$2.840.40%N/A10.99%17 Years
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
N/AN/AN/AN/AN/A

Latest OMI, HSIC, MCK, and COR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
McKesson Corporation stock logo
MCK
McKesson
quarterly$0.710.4%6/2/20256/2/20257/1/2025
5/8/2025
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.550.8%5/16/20255/16/20256/2/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cencora, Inc. stock logo
COR
Cencora
6.01
0.87
0.52
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.50
1.38
0.75
McKesson Corporation stock logo
MCK
McKesson
N/A
0.90
0.53
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
3.32
1.13
0.41

Institutional Ownership

CompanyInstitutional Ownership
Cencora, Inc. stock logo
COR
Cencora
97.52%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
96.62%
McKesson Corporation stock logo
MCK
McKesson
85.07%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
98.04%

Insider Ownership

CompanyInsider Ownership
Cencora, Inc. stock logo
COR
Cencora
10.80%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
1.08%
McKesson Corporation stock logo
MCK
McKesson
0.08%
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
3.69%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cencora, Inc. stock logo
COR
Cencora
46,000193.82 million172.89 millionOptionable
Henry Schein, Inc. stock logo
HSIC
Henry Schein
25,000121.72 million120.41 millionOptionable
McKesson Corporation stock logo
MCK
McKesson
45,000125.11 million125.01 millionOptionable
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
23,20077.25 million74.40 millionOptionable

Recent News About These Companies

Head to Head Survey: Owens & Minor (OMI) vs. Its Competitors
Owens & Minor Inc. Advanced Charts | OMI | Barron's
Why Owens & Minor (OMI) Shares Are Trading Lower Today
Owens & Minor, Inc. (OMI) - Yahoo Finance
OMI - Owens & Minor Inc Key Metrics - Morningstar
OMI - Owens & Minor Inc Executives - Morningstar
Owens & Minor scraps plan to acquire home medical supply company
Owens & Minor Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cencora stock logo

Cencora NYSE:COR

$294.58 -3.25 (-1.09%)
Closing price 07/17/2025 03:59 PM Eastern
Extended Trading
$293.88 -0.70 (-0.24%)
As of 07:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Henry Schein stock logo

Henry Schein NASDAQ:HSIC

$69.50 +0.18 (+0.26%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$69.39 -0.11 (-0.16%)
As of 07/17/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

McKesson stock logo

McKesson NYSE:MCK

$710.87 -4.87 (-0.68%)
Closing price 07/17/2025 03:59 PM Eastern
Extended Trading
$707.00 -3.87 (-0.54%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Owens & Minor stock logo

Owens & Minor NYSE:OMI

$8.00 +0.07 (+0.86%)
Closing price 07/17/2025 03:59 PM Eastern
Extended Trading
$8.14 +0.14 (+1.71%)
As of 07:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.